MKS Instruments, Inc. (NASDAQ:MKSI) has been given a consensus recommendation of “Buy” by the seven analysts that are covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $84.00.
MKSI has been the topic of a number of research reports. BidaskClub downgraded MKS Instruments from a “buy” rating to a “hold” rating in a report on Thursday, July 6th. Deutsche Bank AG initiated coverage on MKS Instruments in a report on Wednesday, July 5th. They issued a “buy” rating and a $84.00 price objective on the stock. ValuEngine upgraded MKS Instruments from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Finally, Stifel Nicolaus restated a “buy” rating and issued a $98.00 price objective (up from $90.00) on shares of MKS Instruments in a report on Thursday, July 27th.
ILLEGAL ACTIVITY NOTICE: This report was first published by Stock Observer and is owned by of Stock Observer. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://www.thestockobserver.com/2017/09/13/mks-instruments-inc-mksi-given-consensus-rating-of-buy-by-analysts.html.
In related news, VP Brian Charles Quirk sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $79.30, for a total transaction of $158,600.00. Following the sale, the vice president now directly owns 15,785 shares in the company, valued at approximately $1,251,750.50. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Peter Hanley sold 1,000 shares of the firm’s stock in a transaction dated Friday, July 28th. The shares were sold at an average price of $83.22, for a total value of $83,220.00. Following the sale, the director now owns 3,372 shares in the company, valued at $280,617.84. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 3,850 shares of company stock worth $309,843. Company insiders own 1.65% of the company’s stock.
Several large investors have recently made changes to their positions in the stock. BlackRock Inc. raised its holdings in shares of MKS Instruments by 50,850.9% during the 1st quarter. BlackRock Inc. now owns 6,584,897 shares of the scientific and technical instruments company’s stock valued at $452,712,000 after buying an additional 6,571,973 shares during the period. Vanguard Group Inc. raised its holdings in shares of MKS Instruments by 3.5% during the 2nd quarter. Vanguard Group Inc. now owns 4,872,574 shares of the scientific and technical instruments company’s stock valued at $327,924,000 after buying an additional 163,192 shares during the period. State Street Corp raised its holdings in shares of MKS Instruments by 4.9% during the 2nd quarter. State Street Corp now owns 1,350,159 shares of the scientific and technical instruments company’s stock valued at $90,865,000 after buying an additional 63,140 shares during the period. Bank of New York Mellon Corp raised its holdings in shares of MKS Instruments by 32.6% during the 1st quarter. Bank of New York Mellon Corp now owns 946,072 shares of the scientific and technical instruments company’s stock valued at $65,042,000 after buying an additional 232,778 shares during the period. Finally, OppenheimerFunds Inc. raised its holdings in shares of MKS Instruments by 7.6% during the 1st quarter. OppenheimerFunds Inc. now owns 925,777 shares of the scientific and technical instruments company’s stock valued at $63,648,000 after buying an additional 65,689 shares during the period. Institutional investors and hedge funds own 95.84% of the company’s stock.
MKS Instruments (NASDAQ MKSI) opened at 85.95 on Wednesday. The firm has a market capitalization of $4.66 billion, a P/E ratio of 17.85 and a beta of 1.08. MKS Instruments has a 52-week low of $46.51 and a 52-week high of $88.40. The firm has a 50-day moving average price of $81.09 and a 200 day moving average price of $75.49.
MKS Instruments (NASDAQ:MKSI) last released its quarterly earnings data on Tuesday, July 25th. The scientific and technical instruments company reported $1.41 EPS for the quarter, hitting analysts’ consensus estimates of $1.41. The company had revenue of $481.00 million for the quarter, compared to the consensus estimate of $463.86 million. MKS Instruments had a return on equity of 19.47% and a net margin of 15.47%. The company’s quarterly revenue was up 47.6% compared to the same quarter last year. During the same period last year, the business posted $0.72 EPS. Analysts forecast that MKS Instruments will post $5.42 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 8th. Stockholders of record on Monday, August 28th were issued a $0.175 dividend. The ex-dividend date was Thursday, August 24th. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.81%. MKS Instruments’s dividend payout ratio (DPR) is 14.58%.
About MKS Instruments
MKS Instruments, Inc is a global provider of instruments, subsystems and process control solutions that measures, controls, powers, delivers, monitors and analyzes critical parameters of advanced manufacturing processes. The Company operates through two segments, including the Vacuum & Analysis segment and the Light & Motion segment.
Receive News & Ratings for MKS Instruments Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments Inc. and related companies with MarketBeat.com's FREE daily email newsletter.